This pilot trial evaluates whether a vibrating device can improve walking ability (gait) in patients who have peripheral neuropathy-associated gait dysfunction. Peripheral neuropathy is a disorder of the peripheral nervous system that manifests as pain, tingling, numbness, and muscle weakness. It is a common diagnosis among people with cancer and especially those who have undergone chemotherapy. Individual muscle vibration has the potential to improve disordered gait, but there is not a commercially available vibration system available, and there are still many questions surrounding the outcomes of the use of this treatment. This pilot trial seeks to answer some of those questions.
Additional locations may be listed on ClinicalTrials.gov for NCT05061238.
Locations matching your search criteria
United States
Texas
Houston
M D Anderson Cancer CenterStatus: Active
Contact: David McCall
Phone: 713-792-6604
PRIMARY OBJECTIVE:
I. To assess the effect of a vibrating device applied to randomly selected muscles on the step times of adolescent or young adult (AYA) patients with peripheral neuropathy.
SECONDARY OBJECTIVES:
I. To summarize the adverse events of different levels from using the vibrator device in oncologic AYA patients visiting the outpatient clinic.
II. To summarize the irritation, pain, and sensation of the application of vibration by the AYA patients, as determined by the survey during the application.
OUTLINE:
Patients walk 7 passes on the walkway for each of the 5 randomly ordered vibration treatment conditions (4 different conditions of bilateral vibrator device placement, and 1 condition of no vibrator device) over 15 minutes.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationM D Anderson Cancer Center
Principal InvestigatorDavid McCall